D.E. Shaw & Co
TAK icon

D.E. Shaw & Co’s Takeda Pharmaceutical TAK Stock Holding History

D.E. Shaw & Co’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-113,678
Closed -$2.24M – 4246
2019
Q4 		$2.24M Hold
113,678
– – ﹤0.01% 2369
2019
Q3 		$1.96M Hold
113,678
– – ﹤0.01% 2367
2019
Q2 		$2.01M Hold
113,678
– – ﹤0.01% 2238
2019
Q1 		$2.32M Buy
+113,678
New +$2.29M ﹤0.01% 2054

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co's TAK Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Takeda Pharmaceutical (TAK) stake by 39% in Q1 2026, selling an estimated $29.7M and leaving 2,602,543 shares worth $48.2M. The position accounts for 0.03% of the portfolio, ranked #677.

D.E. Shaw & Co first reported a position in TAK in Q1 2019 and has held it in 17 quarters since. The position peaked at $66.9M in Q4 2025. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • D.E. Shaw & Co held 2,602,543 shares of Takeda Pharmaceutical worth $48.2M as of Q1 2026.
  • D.E. Shaw & Co sold 1,691,207 Takeda Pharmaceutical shares in Q1 2026, an estimated $29.7M.
  • Takeda Pharmaceutical made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #677 holding.
  • D.E. Shaw & Co first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 17 quarters since.
  • D.E. Shaw & Co's Takeda Pharmaceutical position peaked at $66.9M in Q4 2025.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.